Tokiwa Bio Inc. was adopted by the Japan Agency for Medical Research and Development (AMED) project for “Basic Technology Development Project for Industrialization of Regenerative Medicine / Gene Therapy (Acceleration Support for Development of Regenerative Medicine Seeds)” in FY2019.
Name of research and development project “Practical application of ultra-high-performance, general-purpose cell reprogramming technology”